Dr. Philip Chan's research focuses on how HIV is transmitted in the community. The research incorporates molecular genetics, phylogenetics, behavioral sciences, and clinical medicine. The results of the research will lead to a better understanding of HIV epidemiology in our community and the development of effective prevention interventions.

Biography

Dr. Philip Chan is an internal medicine and infectious diseases physician at The Miriam Hospital and Rhode Island Hospital, and is Assistant Professor of Medicine at Brown University. Dr. Chan completed a master's degree in molecular genetics and medical school at the University of Vermont. He subsequently came to Brown University where he completed his internal medicine residency and fellowship in infectious diseases. Dr. Chan's main research interest is HIV/AIDS.

Research Description

Dr. Philip Chan's research is translational in nature and incorporates basic and clinical methodology. Dr. Chan studies the molecular evolution of HIV and the use of phylogeny to map transmission networks in the community. Dr. Chan is exploring the dynamics of the HIV epidemic in the community among populations such as men who have sex with men (MSM). Effective prevention interventions are being developed with this research to target and halt the spread of HIV.

Teaching Experience

Our research group always welcomes students of all levels to work on various projects related to HIV/AIDS.

Selected Publications

• Chan PA, Tashima K, Cartwright CP, et al. (2011) "Transmitted drug resistance and molecular epidemiology in antiretroviral naïve HIV-1 infected patients in Rhode Island." AIDS Research and Human Retroviruses 27(3): 275-281.(2011)
• Mayer KH, Ducharme R, Zaller N, Chan PA, Case P, Abbott D, Irma R, Cavanaugh T. (2011). "Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England Bathhouse." JAIDS, Oct 24.(2011)
• Kantor R, Diero L, Delong A, Kamle L, Muyonga S, Mambo F, Walumbe E, Emonyi W, Chan P, Carter EJ, Hogan J, Buziba N. (2009). "Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings." Clinical Infectious Disease 49: 454-462.(2009)
• Chan PA and Kantor R (2009). "Transmitted drug resistance in nonsubtype B HIV-1 infection." HIV Therapy 3: 447-465.(2009)
• Gulick RM, Chan PA, Kantor R. (2008). "Enfuvirtide (T-20)." www.antimicrobe.org.(2008)
• Gulick RM, Chan PA, Kantor R. (2008). "Vicriviroc." www.antimicrobe.org.(2008)
• Chan PA. (2008). "Interpreting missense mutations in Human TRIM5alpha by computational methods." BMC Research Notes 1:116.(2008)
• Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R (2008). "HIV-2 diagnosis and quantification in high-risk patients." AIDS Research and Therapy 5:18.(2008)
• Chan PA and Khan OA. (2007). "Risk factors for HIV infection in Males who have Sex with Males (MSM) in Bangladesh." BMC Public Health 7(1): 153.(2007)